Cormorant Asset Management initiated a new position in Olema Pharmaceuticals (NASDAQ:OLMA), buying 2,750,000 shares worth $68.75 million in the fourth quarter, according to a February 17, 2026, SEC filing. What happened Cormorant Asset Management disclosed a new position in Olema Pharmaceuticals in a quarterly U.S. Securities and Exchange Commission filing dated February 17, 2026. The fund acquired 2,750,000 shares worth $68.75 million at the end of the quarterr. What else to know This was a new posit ...